Marktgröße und Marktanteil von Krebsdiagnostika der nächsten Generation bis 2025-2031
Next Generation Cancer Diagnostics Market Report Analysis
Next Generation Cancer Diagnostics Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Agilent Technologies, Inc
- Illumina, Inc
- PerkinElmer Inc
- F. Hoffmann-La Roche Ltd
- GENERAL ELECTRIC
- OPKO Health, Inc.
- QIAGEN
- Thermo Fisher Scientific Inc.
- Abbott
Regional Overview
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Mittlerer Osten und Afrika
Market Segmentation
By Technologie
- QPCR und Multiplexing
- Benchtop-Sequenzer
- Lab-on-a-Chip
- Next Generation Sequencing
- Protein-Microarrays
- DNA-Microarrays
By Anwendung
- Biomarker-Entwicklung
- Proteomanalyse
- CTC-Analyse
- genetische Analyse
- epigenetische Analyse
By Krebsart
- Lungenkrebs
- Darmkrebs
- Brustkrebs
- Prostatakrebs
- andere
By Funktion
- Krebsscreening
- Therapiemonitoring
- Prognosediagnostik
- Risikoanalyse
- Begleitdiagnostik
Get Free Sample For